Expecting Lunar New Year Travel Rush, China Races to Build Giant Quarantine Center

Outside Shijiazhuang, Hebei province, over 4,000 construction workers are building a giant quarantine center of 4,156 units that can house COVID-19 patients within days of diagnosis.

New Wave of COVID-19 Cases

According to WHO’s data, China has 99,414 confirmed cases of COVID-19 with 4,808 deaths as of January 21st. As the Lunar New Year approaches, China expects a new wave of COVID-19 cases where city residents are traveling across the country to meet their families. To alleviate the burden on the healthcare system, China has started constructing a new quarantine location on January 13th on the outskirts of Northern China.

Quarantine Unit

Each unit in the quarantine center is equipped with basic facilities, including internet, bathroom, bedroom, air conditioning, etc. District 1 is currently moving to the last phase. Most of the infrastructures are done with air conditioning and water heaters waiting to be installed. Within days, China has successfully delivered 606 units and is estimated to reach 1,779 in total by the end of January.

Individual Testing of COVID-19

Furthermore, China has scheduled to perform a COVID-19 testing plan in the quarantine center for each individual. Every personnel and quarantine related parties will undergo a nucleic acid amplification testing (NAAT) for COVID-19 from January 20 to 22nd, and there will be 28 testing companies for professional and efficient screening.

Related Article: COVID-19: South Korea and Japan Make New Plans to Fight the Pandemic

References

1. http://www.gov.cn/xinwen/2021-01/19/content_5581124.htm#1
2. http://www.sjz.gov.cn/col/1609405465981/2021/01/21/1611190892875.html
3. http://www.sjz.gov.cn/col/1596014213243/2021/01/20/1611105496040.html
4. https://www.163.com/dy/article/G0SLI3JB0514R9KE.html

Related posts:

COVID-19 News: Singapore, Korea, and China Accelerate Vaccine Approval, Indonesia Devises Detection Strategies COVID-19: WHO Grants Worldwide Emergency Use Approval for First Chinese Vaccine Researchers Report Inactivated COVID-19 Vaccine Confers Protection in Monkeys China’s Abogen Raises $700M to Fund the First Homegrown mRNA COVID-19 Vaccine to Enter Human Trial

Author

Tyler Chen

"Never go to a doctor whose office plants have died."- Erma Bombeck